The patient's subjective dimension within a Psychiatry for the Person -

Article Sidebar

Requires Subscription or Fee PDF (USD 25)
Published: Sep 30, 2011
DOI: https://doi.org/10.5750/ijpcm.v1i3.54

Main Article Content

Rebecca Schennach
Department of Psychiatry Ludwig-Maximilians-University Munich Nussbaumstreet 7 80336 Munich Germany
Michael Riedel
Hans-Jürgen Möller

Abstract

Aim of this article is to present an overview of quality of life as the patient's subjective dimension in psychiatry. Historical aspects as well as the development of the subjective dimension within psychiatric care are discussed. In a first step, different assessment tools to generally measure quality of life and the patient's subjective experience within psychiatry are introduced and the pros and cons will be balanced. In a second step, specific assessment tools developed for specific patient samples such as patients with schizophrenia or patients suffering from an affective illness are furthermore introduced to the reader. Advantages of the application of such assessment strategies also in daily clinical practice are discussed and in a third step relevant therapeutic strategies and consequences of evaluating and considering the patient's subjective dimension within psychiatry are presented. On the background of increasing evidence advising to incorporate the patient's personal and subjective dimension into the treatment procedure this article provides and excellent overview on how to examine and evaluate this subjective dimension and on what therapeutical consequences to adopt to improve the care of patients in psychiatry.

Article Details

Issue
Vol. 1 No. 3 (2011): September
Section
Regular Articles

References

Reference List

Spilker B: Introduction to the field of Quality of life trials; in Spilker B (ed): Quality of Life and Pharmaeconomics in Clinical Trials. Philadelphia, Lippincott-Raven, 1996, pp 1-10.

Lambert M, Naber D: Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 2004;18 Suppl 2:5-17.

Katschnig H: How useful is the concept of quality of life in psychiatry; in Katschnig H, Freeman H, Sartorius N (eds): Quality of life in mental disorders. Chichester, UK, Wiley & Sons, 1997.

Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, Frank E: Functional impairment in the remission phase of bipolar disorder. Bipolar Disord 2005;7:281-285.

Lambert M, Naber D, Eich FX, Schacht M, Linden M, Schimmelmann BG: Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007;115:106-113.

Ten Doesschate MC, Koeter MW, Bockting CL, Schene AH: Health related quality of life in recurrent depression: A comparison with a general population sample. J Affect Disord 13-5-2009.

Voruganti LN, Awad AG: Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 1-7-2002;56:37-46.

Bobes J: Current status of quality of life assessment in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 2001;251 Suppl 2:II38-42.:II38-II42.

Mezzich JE: Psychiatry for the Person: articulating medicine's science and humanism. World Psychiatry 2007;6:65-67.

de HL, Nimwegen L, Amelsvoort T, Dingemans P, Linszen D: Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia. Pharmacopsychiatry 2008;41:125-128.

Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E: Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry 2001;16:293-298.

Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B: Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 30-5-2001;50:79-88.

Katschnig H: Schizophrenia and quality of life. Acta Psychiatr Scand Suppl 2000;33-37.

Moller HJ: Standardised rating scales in Psychiatry: Methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 2009;10:6-26.

Pukrop R, Moller HJ, Steinmeyer EM: Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life". Eur Arch Psychiatry Clin Neurosci 2000;250:120-132.

Hansson L: Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand Suppl 2006;46-50.

Lehman AF: Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol 1996;31:78-88.

gtsson-Tops A, Hansson L: Subjective quality of life in schizophrenic patients living in the community. Relationship to clinical and social characteristics. Eur Psychiatry 1999;14:256-263.

Heinrichs DW, Hanlon TE, Carpenter WT, Jr.: The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388-398.

Schulberg HC, Bromet E: Strategies for evaluating the outcome of community services for the chronically mentally ill. Am J Psychiatry 1981;138:930-935.

Lehman A.F.: A Quality of Life Interview for the chronically mentally ill (QOLI). Eval Prog Planning 1988;51-62.

Lehman A.F.: Instruments for measuring quality of life; in Katschnig H, Freeman H, Sartorius N (eds): Quality of life in mental disorders. Chichester UK, Wiley & Sons, 1997.

Campbell J, Schraiber R, Temkin T, ten Tusscher T. The Well-Being Project: Mental Health Clients Speak for Themselves. Report to the California Department of Mental Health. 1989.

Ref Type: Report

Oliver J.P.: The social care directive: development of a quality of life profile for use in community services for the mentally ill. Soc Work Soc Sci Rec 1991;5-45.

The WHOQOL Group: The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;1569-1585.

Ware JE, Jr., Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.

Ware JE, Jr., Snow KK., Kosinski M, et al.: SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass, The Health Institute, New England Medical Center, 1993.

Heinrichs DW, Hanlon TE, Carpenter WT, Jr.: The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388-398.

Naber D: A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995;10 Suppl 3:133-138.

Bobes J, Gonzalez M.P.: Quality of life in Schizophrenia; in Katschnig H, Freeman H, Sartorius N (eds): Qaulity of life in mental disorders. Chichester UK, Wiley & Sons, 1997.

Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E, Cheng S, Rickwood A: The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 2000;102:303-309.

Voruganti LN, Heslegrave RJ, Awad AG: Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci 1997;22:267-274.

Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, Callaghan EO: Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996;94:118-124.

gtsson-Tops A, Hansson L, Sandlund M, Bjarnason O, Korkeila J, Merinder L, Nilsson L, Sorgaard KW, Vinding HR, Middelboe T: Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: a Nordic multicentre study. Qual Life Res 2005;14:221-229.

Sim K, Mahendran R, Siris SG, Heckers S, Chong SA: Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 15-12-2004;129:141-147.

Reine G, Lancon C, Di TS, Sapin C, Auquier P: Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand 2003;108:297-303.

Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW: Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004;65:932-939.

Kasckow JW, Twamley E, Mulchahey JJ, Carroll B, Sabai M, Strakowski SM, Patterson T, Jeste DV: Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res 5-8-2001;103:69-78.

Vandiver VL: Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and U.S.A. Community Ment Health J 1998;34:501-511.

Caron J, Lecomte Y, Stip E, Renaud S: Predictors of quality of life in schizophrenia. Community Ment Health J 2005;41:399-417.

Drake RE, Ehrlich J: Suicide attempts associated with akathisia. Am J Psychiatry 1985;142:499-501.

Frankle WG, Laruelle M: Neuroreceptor imaging in psychiatric disorders. Ann Nucl Med 2002;16:437-446.

Heck AH, Haffmans PM, de G, I, Hoencamp E: Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial. Schizophr Res 15-12-2000;46:97-105.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van H, I, Eerdekens M, Swyzen W, De SG: Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry 2005;162:947-953.

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 22-9-2005;353:1209-1223.

Lambert M, Schimmelmann BG, Schacht A, Karow A, Wagner T, Wehmeier PM, Huber CG, Hundemer HP, Dittmann RW, Naber D: Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years. Schizophr Res 2009;107:165-172.

Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt L.G., Gaebel W, Klosterkötter J, Heuser I, Kühn K-U, Lemke M.R., Rüther E, Klingberg S, Gastpar M, Möller H.-J., Riedel M. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders - valid predictors of symptomatic response and remission? 2009.

Ref Type: Unpublished Work

Schennach-Wolff R, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt L.G., Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke M.R., Rüther E, Buchkremer G, Gastpar M, Jäger M, Möller H.-J., Riedel M. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders. 2009.

Ref Type: Unpublished Work

Voruganti L, Heslegrave R, Awad AG, Seeman MV: Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998;28:165-172.

Moller HJ, Schmid-Bode W, Cording-Tommel C, Wittchen HU, Zaudig M, von ZD: Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up. Acta Psychiatr Scand 1988;77:379-389.

Doyle M, Flanagan S, Browne S, Clarke M, Lydon D, Larkin C, O'Callaghan E: Subjective and external assessments of quality of life in schizophrenia: relationship to insight. Acta Psychiatr Scand 1999;99:466-472.

Pyne JM, Patterson TL, Kaplan RM, Gillin JC, Koch WL, Grant I: Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997;48:224-230.

Bonicatto SC, Dew MA, Zaratiegui R, Lorenzo L, Pecina P: Adult outpatients with depression: worse quality of life than in other chronic medical diseases in Argentina. Soc Sci Med 2001;52:911-919.

Atkinson M, Zibin S, Chuang H: Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997;154:99-105.

Ormel J, Vonkorff M, Oldehinkel AJ, Simon G, Tiemens BG, Ustun TB: Onset of disability in depressed and non-depressed primary care patients. Psychol Med 1999;29:847-853.

Goldney RD, Fisher LJ, Wilson DH, Cheok F: Major depression and its associated morbidity and quality of life in a random, representative Australian community sample. Aust N Z J Psychiatry 2000;34:1022-1029.

Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326.

Stoker MJ, Dunbar GC, Beaumont G: The SmithKline Beecham 'quality of life' scale: a validation and reliability study in patients with affective disorder. Qual Life Res 1992;1:385-395.

Hunt SM, McKenna SP: The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992;22:307-319.

Lasalvia A, Ruggeri M, Santolini N: Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6. Psychother Psychosom 2002;71:275-284.

Hoffmann JP, Baldwin SA, Cerbone FG: Onset of major depressive disorder among adolescents. J Am Acad Child Adolesc Psychiatry 2003;42:217-224.

Arnold LM, Witzeman KA, Swank ML, McElroy SL, Keck PE, Jr.: Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J Affect Disord 2000;57:235-239.

MacQueen GM, Young LT, Robb JC, Marriott M, Cooke RG, Joffe RT: Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr Scand 2000;101:374-381.

Robb JC, Young LT, Cooke RG, Joffe RT: Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. J Affect Disord 1998;49:189-193.

Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS: Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001;42:190-195.

Robb JC, Cooke RG, Devins GM, Young LT, Joffe RT: Quality of life and lifestyle disruption in euthymic bipolar disorder. J Psychiatr Res 1997;31:509-517.

Sclare P, Creed F: Life events and the onset of mania. Br J Psychiatry 1990;156:508-14.:508-514.

Goldberg JF, Harrow M: Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. J Affect Disord 2005;89:79-89.

Mogotsi M, Kaminer D, Stein DJ: Quality of life in the anxiety disorders. Harv Rev Psychiatry 2000;8:273-282.

Schneier FR: Quality of life in anxiety disorders; in Katschnig H, Freeman H, Sartorius N (eds): Quality of life in mental disorders. Chichester, UK, Wiley & Sons, 1997.

Moritz S: A review on quality of life and depression in obsessive-compulsive disorder. CNS Spectr 2008;13:16-22.

Testa MA, Simonson DC: Assesment of quality-of-life outcomes. N Engl J Med 28-3-1996;334:835-840.

Arostegui I, Padierna A, Quintana JM: Assessment of HRQoL in patients with eating disorders by the beta-binomial regression approach. Int J Eat Disord 17-6-2009.

Ochoa S, Haro JM, Autonell J, Pendas A, Teba F, Marquez M: Met and unmet needs of schizophrenia patients in a Spanish sample. Schizophr Bull 2003;29:201-210.

Wiersma D: Needs of people with severe mental illness. Acta Psychiatr Scand Suppl 2006;115-119.

Ritsher JB, Phelan JC: Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res 30-12-2004;129:257-265.

Wolkenstein L, Meyer TD: What factors influence attitudes towards people with current depression and current mania? Int J Soc Psychiatry 2009;55:124-140.

Holzinger A, Beck M, Munk I, Weithaas S, Angermeyer MC: [Stigma as perceived by schizophrenics and depressives]. Psychiatr Prax 2003;30:395-401.

Hayward P, Wong G, Bright JA, Lam D: Stigma and self-esteem in manic depression: an exploratory study. J Affect Disord 2002;69:61-67.

Chue P: The relationship between patient satisfaction and treatment outcomes in schizophrenia. J Psychopharmacol 2006;20:38-56.

Schennach-Wolff R, Jager M, Seemuller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Ruther E, Buchkremer G, Gastpar M, Moller HJ, Riedel M: Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res 26-6-2009.